Philips’ platform approach is built with cybersecurity, privacy, and responsible AI practices at its core. Trust is foundational to enabling data liquidity across the enterprise, supporting ...

Masimo and Philips renewed a multi-year strategic collaboration to integrate patient monitoring technologies and develop new tools, such as artificial intelligence algorithms, that could help improve ...

Dutch health tech giant Royal Philips has scored FDA 510(k) clearance for its IntelliVue MX750 and MX850 patient monitors. The monitors, which received an FDA emergency use authorization in 2020 and ...

Medtronic and Philips have re-upped their long-running partnership focused on bundling vital sign sensors together with patient monitoring equipment. The two medtechs said the collaboration extends ...

Covidien has announced the launch of its Nellcor SpO2 single parameter module for use with the Philips IntelliVue patient monitoring platform, according to a news release. The Nellcor SpO2 module ...

Medtech companies Philips and Masimo are expanding their patient monitoring partnership to include the latter's new W1 wearable. The collaboration allows vital sign data from the W1 watch to be sent ...

At the heart of the expanded partnership is a joint effort to integrate Masimo’s advanced monitoring technologies – including SET® pulse oximetry, Radius PPG, and a range of sensor technology – into ...

Amsterdam, the Netherlands and Irvine, California, U.S. – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Masimo (NASDAQ: MASI), a global medical technology company, ...

More than a year after doling out an emergency use authorization for a handful of Philips’ IntelliVue patient monitoring devices, the FDA is doubling down on the regulatory nod. Two of the patient ...

On the earnings call in August, new CEO Katie Szyman, who joined Masimo in February from BD, sought to reassure investors that the company’s decades-long relationship with Philips remained strong.